Choice of Cost-Effectiveness Measure in the Economic Evaluation of Cholesterol-Modifying Pharmacotherapy: An Illustrative Example Focusing on the Primary Prevention of Coronary Heart Disease in Canada

Author: Morris S.  

Publisher: Adis International

ISSN: 1170-7690

Source: PharmacoEconomics, Vol.16, Iss.2, 1999-08, pp. : 193-205

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract